Cardio Diagnostics Holdings Inc
NASDAQ:CDIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lisi SA
OTC:LSIIF
|
FR |
|
G
|
Genincode PLC
LSE:GENI
|
UK |
Cardio Diagnostics Holdings Inc
Intangible Assets
Cardio Diagnostics Holdings Inc
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cardio Diagnostics Holdings Inc
NASDAQ:CDIO
|
Intangible Assets
$873.2k
|
CAGR 3-Years
34%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
B
|
Baker Hughes Co
NASDAQ:BKR
|
Intangible Assets
$4.1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
22%
|
|
|
Schlumberger NV
NYSE:SLB
|
Intangible Assets
$5B
|
CAGR 3-Years
19%
|
CAGR 5-Years
8%
|
CAGR 10-Years
1%
|
|
|
Halliburton Co
NYSE:HAL
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Symbotic Inc
NASDAQ:SYM
|
Intangible Assets
$79.1m
|
CAGR 3-Years
384%
|
CAGR 5-Years
121%
|
CAGR 10-Years
N/A
|
|
|
R
|
Reddit Inc
NYSE:RDDT
|
Intangible Assets
$15.5m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
83%
|
CAGR 10-Years
N/A
|
|
Cardio Diagnostics Holdings Inc
Glance View
Cardio Diagnostics Holdings Inc is a US-based company operating in industry. The company is headquartered in Dover, Delaware. The company went IPO on 2021-11-23. Cardio Diagnostics Holdings, Inc., formerly Mana Capital Acquisition Corp., is a biotechnology company that helps in cardiovascular disease prevention and early detection accessible. The firm is engaged in the development and commercialization of artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine for cardiovascular disease. The company enables prevention, early detection, and assists in the treatment of cardiovascular disease. The firm's Epi+Gen CHD is a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks. Its Epi+Gen CHD test is categorized as a laboratory-developed test (LDT), which does not require premarket authorization or other Food and Drug Administration (FDA) clearance or approval. The company serves a range of patients, clinicians, hospitals/health systems, employers, and payors.
See Also
What is Cardio Diagnostics Holdings Inc's Intangible Assets?
Intangible Assets
873.2k
USD
Based on the financial report for Dec 31, 2025, Cardio Diagnostics Holdings Inc's Intangible Assets amounts to 873.2k USD.
What is Cardio Diagnostics Holdings Inc's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
34%
Over the last year, the Intangible Assets growth was 24%. The average annual Intangible Assets growth rates for Cardio Diagnostics Holdings Inc have been 34% over the past three years , 34% over the past five years .
